Mitochondria-Induced Immune Response as a Trigger for Neurodegeneration: A Pathogen from Within
- PMID: 34445229
- PMCID: PMC8395232
- DOI: 10.3390/ijms22168523
Mitochondria-Induced Immune Response as a Trigger for Neurodegeneration: A Pathogen from Within
Abstract
Symbiosis between the mitochondrion and the ancestor of the eukaryotic cell allowed cellular complexity and supported life. Mitochondria have specialized in many key functions ensuring cell homeostasis and survival. Thus, proper communication between mitochondria and cell nucleus is paramount for cellular health. However, due to their archaebacterial origin, mitochondria possess a high immunogenic potential. Indeed, mitochondria have been identified as an intracellular source of molecules that can elicit cellular responses to pathogens. Compromised mitochondrial integrity leads to release of mitochondrial content into the cytosol, which triggers an unwanted cellular immune response. Mitochondrial nucleic acids (mtDNA and mtRNA) can interact with the same cytoplasmic sensors that are specialized in recognizing genetic material from pathogens. High-energy demanding cells, such as neurons, are highly affected by deficits in mitochondrial function. Notably, mitochondrial dysfunction, neurodegeneration, and chronic inflammation are concurrent events in many severe debilitating disorders. Interestingly in this context of pathology, increasing number of studies have detected immune-activating mtDNA and mtRNA that induce an aberrant production of pro-inflammatory cytokines and interferon effectors. Thus, this review provides new insights on mitochondria-driven inflammation as a potential therapeutic target for neurodegenerative and primary mitochondrial diseases.
Keywords: antiviral response; inflammation; innate immunity; interferon; mitochondrial disorders; mitochondrial dysfunction; mtDNA; mtRNA; neurodegeneration.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
- ERC-2014-StG-638106/the European Research Council
- SAF2017-88108-R/Ministerio de Economía, Industria y Competitividad, Gobierno de España
- SAF2014-57981P/Ministerio de Economía, Industria y Competitividad, Gobierno de España
- 2017SGR-323/Agència de Gestió d'Ajuts Universitaris i de Recerca
- LCF/PR/HR20/52400018/"la Caixa" Foundation
LinkOut - more resources
Full Text Sources
Medical
